Company
Saros Therapeutics
Delivering Improved Immunotherapy
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- North Chicago, Illinois, United States
Claim, correct or request removal
Record updated 28 September 2026
About
Saros develops novel immunotherapies to improve and extend the lives of patients with cancer and auto-immune diseases.
Funding snapshot
- Total raised
- $2MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Grant, $2M2023-09-21
Funding rounds
- Grant
- $2M2023-09-21, Company stated
Loading relationship preview